4.3 Article

Maternal smoking during pregnancy and intellectual performance in young adult Swedish male offspring

期刊

PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
卷 24, 期 1, 页码 79-87

出版社

WILEY-BLACKWELL PUBLISHING, INC
DOI: 10.1111/j.1365-3016.2009.01073.x

关键词

maternal prenatal smoking; adult IQ; siblings; confounding

资金

  1. Swedish Research Council [K2007-70P-20518-01-4]
  2. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061817] Funding Source: NIH RePORTER

向作者/读者索取更多资源

P>Lundberg F, Cnattingius S, D'Onofrio B, Altman D, Lambe M, Hultman C, Iliadou A. Maternal smoking during pregnancy and intellectual performance in young adult Swedish male offspring. Paediatric and Perinatal Epidemiology 2010; 24: 79-87. Smoking during pregnancy has been linked to an increased risk of several adverse birth outcomes. Associations with deficits in cognitive development have also been suggested. It is unclear whether these associations are due to genetic and/or environmental confounding. In a population-based Swedish cohort study on 205 777 singleton males born to Nordic mothers between 1983 and 1988, we examined the association between maternal smoking during pregnancy and the risk of poor intellectual performance in young adult male offspring. In the cohort analyses, the risk of poor intellectual performance was increased in sons of smoking mothers compared with sons of non-smokers. Stratifying for maternal smoking habits across two pregnancies, there was an increased risk of poor intellectual performance for both sons if the mother was only smoking in the first pregnancy, but in neither son if the mother was only smoking in the second pregnancy. The effect of smoking during pregnancy on intellectual performance was not present when the association was evaluated within sibling pairs. Thus, the association between prenatal smoking exposure and offspring risk of low intellectual performance appears to be completely confounded by familial (genetic and early environmental) factors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Oncological therapy to Swedish men with metastatic penile cancer 2000-2015

Emma Ulvskog, Linda Drevin, Erik K. Persson, Mats Lambe, Peter Kirrander, Johan Ahlgren

Summary: Penile cancer is a rare disease with poor prognosis when it spreads to multiple inguinal lymph nodes. This study in Sweden investigated the treatment and survival outcomes of men with metastatic penile cancer over a 15-year period. The use of oncological treatments with curative intent increased significantly during the study period, and survival was higher among men treated with curative intent.

ACTA ONCOLOGICA (2021)

Article Oncology

Temporal trends in lung cancer survival: a population-based study

Lukas Lofling, Shahram Bahmanyar, Helle Kieler, Mats Lambe, Gunnar Wagenius

Summary: The study investigated temporal trends in lung cancer survival in Sweden from 1995 to 2016, revealing an overall increase in survival rates for lung cancer patients, as well as improved survival in subgroups such as those with stage IV disease. There was also a decrease in excess mortality throughout the study period.

ACTA ONCOLOGICA (2022)

Editorial Material Oncology

Reply to Assoc. Prof. Kocak COMMENT

Linda Willen, Anders Berglund, Stefan Bergstrom, Johan Isaksson, Michael Bergqvist, Gunnar Wagenius, Mats Lambe

ACTA ONCOLOGICA (2022)

Article Oncology

Are older patients with non-small cell lung cancer receiving optimal care? A population-based study

Linda Willen, Anders Berglund, Stefan Bergstrom, Johan Isaksson, Michael Bergqvist, Gunnar Wagenius, Mats Lambe

Summary: The study revealed that older patients with metastatic disease received treatment more readily than those with early stage disease. Significant differences were observed in cause-specific survival in early stage, but not late stage disease. This underscores the importance of individualized assessment of health status and life expectancy.

ACTA ONCOLOGICA (2022)

Article Oncology

The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020

Anna L. Johansson, Siri Laronningen, Charlotte Wessel Skovlund, Marnar Frioheim Kristiansen, Lina Steinrud Morch, Soren Friis, Tom Borge Johannesen, Tor Age Myklebust, Anna Skog, David Pettersson, Helgi Birgisson, Anni Virtanen, Nea Malila, Janne Pitkaniemi, Tomas Tanskanen, Laufey Tryggvadottir, Giske Ursin, Mats Lambe

Summary: The severity of the COVID-19 pandemic and subsequent mitigation strategies have led to a decline in new cancer cases in the Nordic countries, with Sweden experiencing the most significant reduction. Possible explanations include the severity of the pandemic, temporary halting of screening activities, and changes in healthcare seeking behavior.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Oncology

Survival trends in patients diagnosed with colon and rectal cancer in the nordic countries 1990-2016: The NORDCAN survival studies

Frida E. Lundberg, Helgi Birgisson, Tom B. Johannesen, Gerda Engholm, Anni Virtanen, David Pettersson, Elinborg J. Olafsdottir, Mats Lambe, Paul C. Lambert, Lina S. Morch, Anna L. Johansson, Therese M-L Andersson

Summary: The survival of patients with colon and rectal cancer has improved in all Nordic countries over the past decades. The study shows that the survival rate has improved for both men and women in all age groups. The largest improvement was observed in Danish men and women with rectal cancer. The probability of death and life-years lost varied across countries.

EUROPEAN JOURNAL OF CANCER (2022)

Article Oncology

Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms-a nationwide population-based study of 342 pregnancies in Sweden

Anna Ravn Landtblom, Therese M-L Andersson, Anna L. Johansson, Sophia Brismar Wendel, Frida E. Lundberg, Jan Samuelsson, Magnus Bjorkholm, Malin Hultcrantz

Summary: Pregnancy and childbirth in women with myeloproliferative neoplasms (MPN) are associated with increased risk of preterm birth and decreased risk of maternal complications compared to previous reports.

LEUKEMIA (2022)

Article Oncology

Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis

Anna Marklund, Tobias Lekberg, Elham Hedayati, Annelie Liljegren, Jonas Bergh, Frida E. Lundberg, Kenny A. Rodriguez-Wallberg

Summary: This study found that the use of hormonal stimulation during fertility preservation procedures did not increase the risk of relapse or disease-specific mortality in women with breast cancer.

JAMA ONCOLOGY (2022)

Article Oncology

Potential overtreatment in end-of-life care in adults 65 years or older dying from cancer: applying quality indicators on nationwide registries

Mate Szilcz, Jonas W. Wastesson, Lucas Morin, Amaia Calderon-Larranaga, Mats Lambe, Kristina Johnell

Summary: This study aimed to identify quality indicators of overtreatment at the end of life among older adults with solid cancer, finding that about one-third of decedents received potentially overtreatment during their last month of life.

ACTA ONCOLOGICA (2022)

Article Oncology

Age-specific survival trends and life-years lost in women with breast cancer 1990-2016: the NORDCAN survival studies

Frida E. Lundberg, Niels Kroman, Mats Lambe, Therese M. -L. Andersson, Gerda Engholm, Tom Borge Johannesen, Anni Virtanen, David Pettersson, Elinborg J. Olafsdottir, Helgi Birgisson, Paul C. Lambert, Lina Steinrud Morch, Anna L. V. Johansson

Summary: The survival rates for Nordic women with breast cancer improved from 1990 to 2016 in all age groups, with larger country variations among older women where survival rates were lower. Women over the age of 70 have not seen the same level of survival improvement as younger women.

ACTA ONCOLOGICA (2022)

Article Pediatrics

Obstetric and Perinatal Outcomes of Singleton Births Following Single- vs Double-Embryo Transfer in Sweden

Kenny A. Rodriguez-Wallberg, Arturo Reyes Palomares, Hanna P. Nilsson, Anna Sara Oberg, Frida Lundberg

Summary: Pregnancies resulting from assisted reproductive technology have a higher risk of adverse perinatal outcomes compared to natural conception. This study aimed to compare the risk of adverse outcomes in singletons conceived through double-embryo transfer (DET) and single-embryo transfer (SET). The results indicate a higher risk of adverse outcomes in singletons born after DET, particularly when using frozen embryos and blastocysts.

JAMA PEDIATRICS (2023)

Article Obstetrics & Gynecology

Risk of obstetric and perinatal complications in women presenting with breast cancer during pregnancy and the first year postpartum in Sweden 1973-2017: A population-based matched study

Frida E. Lundberg, Leo Gkekos, Kenny A. Rodriguez-Wallberg, Irma Fredriksson, Anna L. V. Johansson

Summary: Breast cancer diagnosed during pregnancy increases the risks of preterm birth and low birthweight, but is not associated with other maternal pregnancy complications or adverse outcomes in children.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2023)

Article Oncology

Influence of various assumptions for the individual TNM components on the TNM stage using Nordic cancer registry data

Gerda Engholm, Frida E. Lundberg, Simon M. Konig, Elinborg Olafsdottir, Tom B. Johannesen, David Pettersson, Lina S. Morch, Anna L. V. Johansson, Soren Friis

Summary: This study aimed to evaluate the influence of assuming missing N and M as N0 and M0 on available TNM stage, stage distribution, and stage-specific relative survival in cancer patients. The results showed that assuming N0M0 for missing N and M had minor effects on stage-specific one-year relative survival, especially for high completeness of TNM registrations. Therefore, while complete TNM information is preferred, assuming N0M0 for missing N and M may be reasonable in future studies based on Nordic cancer registries. Rating: 8/10

ACTA ONCOLOGICA (2023)

Article Oncology

Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis

Anna Marklund, Tobias Lekberg, Elham Hedayati, Annelie Liljegren, Jonas Bergh, Frida E. Lundberg, Kenny A. Rodriguez-Wallberg

Summary: The study found that undergoing fertility preservation with or without hormonal stimulation at the time of breast cancer diagnosis did not increase the risk of relapse or disease-specific mortality. This provides important evidence on the safety of fertility preservation procedures in women with breast cancer and may impact healthcare practices for young women with breast cancer who wish to preserve their fertility.

JAMA ONCOLOGY (2022)

暂无数据